Non-valvular Atrial Fibrillation
Conditions
Keywords
Patients, treated by Rivaroxaban
Brief summary
This study is multicentric, single-blind, and interventional with a randomization into two parallel arm, between a standard of care information and an additional information of the patient, with a 12 month follow up. The aim of this study is to evaluate the effectiveness of a personalized information program versus information provided from standard of care in patients taking Xarelto for Stroke Prevention in Atrial Fibrillation.
Interventions
DRUGXarelto
Taking conventional charge
OTHERExperimental: Personalized information intervention
Sponsors
University Hospital, Montpellier
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients treated with rivaroxaban chronically, (atrial fibrillation non-valvular under current AMM) for less than one year whatever anti vitamin K treatment history * Affiliate or beneficiary of a social security system. * Patient who formulated its does not oppose to participate in this research * Age higher than or equal to 18 years
Exclusion criteria
* Opposition to participation * Patient don't understand french language * Patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers) * Tutorship or curatoship * Law-protected patient * Pregnant women or breast-feeding
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The occurence of serious adverse event | 12 months | The occurence of serious adverse event |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The number ok hospitalization | 12 months | The number ok hospitalization |
Countries
France
Outcome results
None listed